Posted on April 10, 2009 by Sitemaster
Today’s news reports deal with:
- A comparative, single institution study of RALP vs RRP
- Bone mineral density and osteoporosis in men treated with intermittent hormone therapy
- Transdermal testosterone therapy in men with castration-resistant prostate cancer
In a separate report we have discussed the development of a pre-biopsy risk assessment nomogram that incorporates results from PCA3 testing. … READ MORE …
Filed under: Management, Treatment | Tagged: BMD, bone mineral density, intermittent hormone therapy, osterporosis, RALP, retropubic radical prostatectomy, robot-assisted laparoscopic prostatectomy, RRP, testosterone therapy | Leave a comment »
Posted on April 3, 2009 by Sitemaster
This morning’s news reports cover:
- Decision making and prostate cancer testing among African Americans
- Inflammation and prostate cancer etiology
- Minimally invasive penile prosthesis surgery
- High-intensity focused ultrasound in first-line treatment
- Intermittent hormone therapy … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: African American, HIFU, inflammation, intermittent hormone therapy, penile prosthesis surgery | Leave a comment »
Posted on March 30, 2009 by Sitemaster
Two European studies that have just been published appear to validate the long-term concept of intermittent hormone therapy (IHT). … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: intermittent hormone therapy | 4 Comments »
